Form 4: VIAVI Executive Sells Shares Under 10b5-1 Plan
Insider Transaction Report
VIAVI Solutions SVP Kevin Siebert sold 13,577 shares of common stock for a weighted average price of $25.72 per share under a Rule 10b5-1 plan.
Summary
- Kevin Christopher Siebert, SVP Gen. Counsel & Secretary of VIAVI SOLUTIONS INC. (VIAV), reported a sale of common stock.
- The transaction involved the disposition of 13,577 shares of VIAVI Common Stock.
- The shares were sold at a weighted average price of $25.72 per share.
- The total value of the transaction was approximately $349,489.64 (13,577 shares * $25.72/share).
- The sale was executed on February 2, 2026.
- Following this transaction, Mr. Siebert beneficially owns 35,648 shares of Common Stock.
- The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was pre-planned under a Rule 10b5-1 plan, indicating a scheduled liquidity event rather than a reaction to new information.
Positives
- The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than a reaction to immediate market events, which can reduce concerns about opportunistic insider trading.
Negatives
- An executive selling shares, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of conviction, though this is often a routine liquidity event.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those under Rule 10b5-1 plans, are common across all industries as executives manage personal finances and diversify portfolios. This specific transaction by a VIAVI executive is a routine disclosure and does not inherently suggest broader industry trends or competitive shifts.
Stakeholder Impact
- Shareholders: The sale of shares by an executive could be viewed neutrally to slightly negatively, though the 10b5-1 plan mitigates concerns about opportunistic selling. It represents a minor reduction in insider ownership.
Key Dates
| Date | Description |
|---|---|
| 02/02/2026 | Date of transaction (sale of common stock) |
| 02/03/2026 | Signature date of the reporting person's attorney-in-fact |
Recommendation
holdThe Form 4 reports a pre-scheduled insider sale under a Rule 10b5-1 plan, which is a routine liquidity event and does not inherently signal a change in the company's fundamental outlook. Therefore, it does not warrant a change from a 'hold' position based solely on this filing.
Keywords
VIAVI Solutions, VIAV, insider trading, Form 4, stock sale, executive compensation, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.